Advent International and Essex Woodlands fully exited Brazilian pharmaceutical company Biotoscana through a strategic sale to Canadian pharmaceutical company Knight Therapeutics. Advent and Essex Woodlands ‘s 51% stake was purchased…
-
-
Advent International has partially exited Uruguay-based pharmaceutical company Biotoscana through an initial public offering of Brazilian Depositary Shares (BDRs) on Brazil’s B3 stock exchange. (Valor Econômico) A oferta pública inicial…